Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Bejon

Showing results (191-200 of 276) with videos related to

Pageof 28
Sort By:
International Journal for Parasitology. Drugs and Drug Resistance|June 19, 2021
A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in AfricaLeonard Ndwiga, Kelvin M Kimenyi, Kevin Wamae, et al.
The Lancet. Infectious Diseases|May 1, 2023
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trialAitana Juan-Giner, Maria L Namulwana, Derick Kimathi, et al.
Frontiers in Immunology|July 22, 2025
R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trialElizabeth Kibwana, Caroline Bundi, Domtila Kimani, et al.
Elife|July 6, 2021
Improving statistical power in severe malaria genetic association studies by augmenting phenotypic precisionJames A Watson, Carolyne M Ndila, Sophie Uyoga, et al.
Plos Medicine|May 13, 2022
Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014-2018: A cohort studyDoris K Nyamwaya, Mark Otiende, Lilian Mwango, et al.
BMC Global and Public Health|September 9, 2025
Genomic and clinical epidemiology of SARS-CoV-2 in coastal Kenya: insights into variant circulation, reinfection, and multiple lineage importations during a post-pandemic waveArnold W Lambisia, Esther N Katama, Edidah Moraa, et al.
Plos One|May 10, 2014
A genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in KenyaJason P Wendler, John Okombo, Roberto Amato, et al.
Wellcome Open Research|May 4, 2022
Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal KenyaJames Nyagwange, Leonard Ndwiga, Kelvin Muteru, et al.
Wellcome Open Research|May 30, 2024
Safety and immunogenicity of varied doses of R21/Matrix-M™ vaccine at three years follow-up: A phase 1b age de-escalation, dose-escalation trial in adults, children, and infants in Kilifi-KenyaSamuel Sang, Mehreen S Datoo, Edward Otieno, et al.
Msphere|April 16, 2025
Protein-specific immune response elicited by the <i>Shigella sonnei</i> 1790GAHB GMMA-based candidate vaccine in adults with varying exposure to <i>Shigella</i>Arlo Z Randall, Valentino Conti, Usman Nakakana, et al.
Pageof 28

Showing results (191-200 of 276) with videos related to

Sort By:
Pageof 28
International Journal for Parasitology. Drugs and Drug Resistance|June 19, 2021
A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in AfricaLeonard Ndwiga, Kelvin M Kimenyi, Kevin Wamae, et al.
The Lancet. Infectious Diseases|May 1, 2023
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trialAitana Juan-Giner, Maria L Namulwana, Derick Kimathi, et al.
Frontiers in Immunology|July 22, 2025
R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trialElizabeth Kibwana, Caroline Bundi, Domtila Kimani, et al.
Elife|July 6, 2021
Improving statistical power in severe malaria genetic association studies by augmenting phenotypic precisionJames A Watson, Carolyne M Ndila, Sophie Uyoga, et al.
Plos Medicine|May 13, 2022
Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014-2018: A cohort studyDoris K Nyamwaya, Mark Otiende, Lilian Mwango, et al.
BMC Global and Public Health|September 9, 2025
Genomic and clinical epidemiology of SARS-CoV-2 in coastal Kenya: insights into variant circulation, reinfection, and multiple lineage importations during a post-pandemic waveArnold W Lambisia, Esther N Katama, Edidah Moraa, et al.
Plos One|May 10, 2014
A genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in KenyaJason P Wendler, John Okombo, Roberto Amato, et al.
Wellcome Open Research|May 4, 2022
Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal KenyaJames Nyagwange, Leonard Ndwiga, Kelvin Muteru, et al.
Wellcome Open Research|May 30, 2024
Safety and immunogenicity of varied doses of R21/Matrix-M™ vaccine at three years follow-up: A phase 1b age de-escalation, dose-escalation trial in adults, children, and infants in Kilifi-KenyaSamuel Sang, Mehreen S Datoo, Edward Otieno, et al.
Msphere|April 16, 2025
Protein-specific immune response elicited by the <i>Shigella sonnei</i> 1790GAHB GMMA-based candidate vaccine in adults with varying exposure to <i>Shigella</i>Arlo Z Randall, Valentino Conti, Usman Nakakana, et al.
Pageof 28